drugset / Trial / NCT02739529
Study to Evaluate the Efficacy and Safety of Genexol-PM Once a Week for Gynecologic Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Dose-dense paclitaxel (Genexol®-PM) once a week in combination with carboplatin every 3 weeks for gynecologic cancer (adult solid tumor): a phase I trial.
Timeline
- Start
- 2016-04
- Primary completion
- 2018-03
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 100 mg/m2 | Intravenous |
| Subject | Paclitaxel | Small molecule | 120 mg/m2 | Intravenous |